Market Monitor Den kemiske branche Spanien 2017

Market Monitor

  • Spanien
  • Kemi/Medicinalvarer

20 Jul 2017

Produktionen af kemikalier forventes at stige omkring 2,5 % i 2017 og 2018, mens antallet af betalingsforsinkelser og konkurser fortsat vil være på et lavt niveau.

  • Spanish chemicals production increased 3% in 2016, while turnover grew just 1.7% (up to EUR 59 billion), mainly due to lower international sales prices. Production growth is expected to increase about 2.5% in 2017 and 2018. Profit margins remained stable over the past 12 months, mainly due to less volatility in oil prices, and this should continue in H2 of 2017 and into 2018.
  • In general, access to bank financing for chemicals businesses has improved in recent years, for both short-term financing (working capital management) and long-term facilities (i.e. capital expenditure financing). Gearing of businesses in this sector is generally low.
  • Payments in the Spanish chemicals sector take 60 days on average. The number of payment delays and insolvencies has been very low over the last couple of years, and this is expected to remain unchanged in H2 of 2017 and into 2018, due to fairly stable commodity prices and the positive growth outlook of the Spanish economy, which is forecast to grow 2.8% in 2017 and 2.2% in 2018.
  • Our underwriting stance for all major chemicals subsectors remains relaxed for the time being. We continuously monitor how the development of commodity prices affects the cash flow generation of businesses and their ability to pass on price changes to the final costumer. Special attention is given to highly geared companies, assessing the evolution of their debt burden and the reasons of any significant debt increase.

 

Relaterede dokumenter

Ansvarsfraskrivelse

Oplysningerne heri er udelukkende informative og må ikke bruges til andre formål. Se venligst den aktuelle police eller den relevante produkt- eller serviceaftale for de gældende betingelser. Intet heri medfører nogen rettighed, forpligtelse eller ansvar på vegne af Atradius, herunder enhver forpligtelse til at foretage due diligence af købere eller på dine vegne. Hvis Atradius foretager en due diligence vedr. en køber, er det for egne forsikringstekniske formål og ikke til fordel for den forsikrede eller nogen anden person. Ydermere må Atradius eller dets tilknyttede virksomheder eller datterselskaber ikke på noget tidspunkt være ansvarlig for direkte, indirekte, konkret dokumenterede tab eller følgetab, der måtte opstå som følge af brugen af udtalelserne i denne information